Insider · CIK 0001689876
Daniel T Whalen
director
Files at HLIT (HARMONIC INC). First filing Feb 24, 2025, latest Feb 26, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 0
$40k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HLIT: HARMONIC INC
HLITOct 9, 2026 · close 10.99
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | HARMONIC INC | $9,990 1,000 shares | +11% | - | |
| 45Moderate | HARMONIC INC | $30k 3,000 shares | +51% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 25, 2025 | HLIT HARMONIC INC | POpen-market purchase Common Stock | +1,000 | $9.99 | $9,990 | 9,840 | Feb 26, 2025 |
| Feb 24, 2025 | HLIT HARMONIC INC | POpen-market purchase Common Stock | +2,000 | $10.19 | $20k | 7,840 | Feb 24, 2025 |
| Feb 24, 2025 | HLIT HARMONIC INC | POpen-market purchase Common Stock | +1,000 | $10.08 | $10k | 8,840 | Feb 24, 2025 |
| Feb 20, 2025 | HLIT HARMONIC INC | AGrant or award Restricted Stock Unitsderivative | +16,143 | $0.00 | $0 | 16,143 | Feb 24, 2025 |
| Feb 15, 2025 | HLIT HARMONIC INC | MOption exercise Common Stock | +5,840 | $0.00 | $0 | 5,840 | Feb 19, 2025 |
| Feb 15, 2025 | HLIT HARMONIC INC | MOption exercise Restricted Stock Unitsderivative | -5,840 | $0.00 | $0 | 0 | Feb 19, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.